# Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

> **NCT06576232** · — · COMPLETED · sponsor: **Median Technologies** · enrollment: 1147 (actual)

## Conditions studied

- High Risk Cancer

## Interventions

- **DEVICE:** Median LCS

## Key facts

- **NCT ID:** NCT06576232
- **Lead sponsor:** Median Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-21
- **Primary completion:** 2024-07-24
- **Final completion:** 2024-08-21
- **Target enrollment:** 1147 (ACTUAL)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06576232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06576232, "Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06576232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*